# Alice P. Chen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alice-p-chen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,304 |
| Field | PARP inhibition in cancer therapy |
| h-index | 67 |
| i10-index | 224 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5045409088 |
| ORCID iD | https://orcid.org/0000-0002-1426-853X |
| Works | 750 |

## Researcher papers

- [Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer](https://scholariq.org/papers/randomized-double-blind-phase-ii-study-of-temozolomide-in-combination-with/)

## Researcher topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.